Methods and compositions for genome modification
AssigneePioneer Hi-Bred International, Inc.
InventorsMAREN L. ARLING, WILLIAM JAMES GORDON-KAMM, JOSHUA K. YOUNG
Life of this patent
Estimating the term…
Loading patent…
AssigneePioneer Hi-Bred International, Inc.
InventorsMAREN L. ARLING, WILLIAM JAMES GORDON-KAMM, JOSHUA K. YOUNG
Estimating the term…
Methods and compositions are provided for the transient expression and activity of site-specific DNA modifying agent, morphogenic factors or developmental genes, either alone or in combination for eukaryotic cells. The morphogenic factor and DNA modifying agent may be provided to the same cell or to a different cell than that which was originally transformed. The morphogenic factor, or the double-strand-break-inducing agent, may further comprise a cell penetrating peptide. Exogenously provided DNA modifying agents and/or morphogenic factors need not be segregated away in future generations due to transient activities in the desired cell.
A method of modifying a target site in the genome of a plant cell, comprising:
A method of modifying a target site in the genome of a plant cell, comprising:
A method of modifying a target site in the genome of a plant cell, comprising:
A synthetic composition comprising two distinct Rhizobiales bacteria,
A synthetic composition comprising two different Rhizobiales bacteria,
A synthetic composition comprising one Rhizobiales strain comprising first and second plasmids, wherein each of the two plasmids comprise one or more distinct T-DNA sequences,
A method of modifying a target site in the genome of a plant cell through endogenous activation of one or more genes, the method comprising providing to the cell (a) a first polynucleotide encoding a deactivated CRISPR-Cas polypeptide (dCas) that is capable of site-specifically binding to an endogenous target site comprising a polynucleotide involved in cellular regeneration, but incapable of introducing a double-strand break at the endogenous target site, wherein the dCas is operably linked to a transcriptional activator, the transcriptional activator capable of increasing the expression of the polynucleotide involved in cellular regeneration;
A synthetic composition comprising (a) a first polynucleotide encoding a deactivated CRISPR-Cas polypeptide (dCas) that is capable of site-specifically binding to an endogenous target site comprising a polynucleotide involved in cellular regeneration, but incapable of introducing a double-strand break at the endogenous target site, wherein the dCas is operably linked to a transcriptional activator, the transcriptional activator capable of increasing the expression of the polynucleotide involved in cellular regeneration;
A method of regeneration of a genome modified plant, the method comprising providing one or more polynucleotides that encode a site-specific DNA modifying agent and optionally, a morphogenic factor to a plant cell, wherein the DNA modifying agent and optionally, the morphogenic factor diffuses or is transported into one or more adjacent plant cells;
Dependencies are inferred from the claim text.